Studie weitere Studien Pharmaindustrie / Gesundheit

Consumer health maintained a strong growth trend in 2012, following on from the previous two years. This growing trend is recorded for the entire Argentine Pharmaceutical Industry, according to the latest reports issued by INDEC (National Institute of Statistics and Census) as regards the same period in 2011.

Euromonitor International's Consumer Health in Argentina report offers a comprehensive guide to the size and shape of... mehr

Bottled water consumption in Colombia was, before 2012, importantly based on a fundamental need and convenience (except for niche-oriented carbonated natural mineral bottled water brands such as Perrier and S Pellegrino) more than on a demand for additional benefits as has happened in other soft drinks categories thanks to the increase of fortified and functional products. The lack of safe water supply in vast regions of the country has... mehr

Current value sales of consumer health increased in Denmark in 2012. In comparison to earlier years of the review period, sales marginally improved, with the main categories, such as analgesics, digestive remedies and dermatologicals all recording growth in 2012. Less dominant categories in consumer health, such as NRT smoking cessation aids and calming and sleeping, experienced a decline in value sales. A relatively improved economic c... mehr

Consumer health saw weaker value growth in 2012 when compared to the results achieved in the review period. In 2012 the category posted value growth of 7% in current terms, while the CAGR of the review period was 8%. However, the category is still showing a healthy performance, mainly driven by an increased consumer base, since a rising number of consumers are becoming more familiar with these products and have higher disposable incomes... mehr

As affordable necessities in Chinese consumers’ daily lives, hosiery in China was less affected by the economic downturn compared with other apparel categories like men’s and women’s clothing in 2012. Immune from the economic recession, hosiery continued to witness dynamic growth in 2012 with retail value grew by 14%, which was higher than historical CAGR of 10% over the review period.

Euromonitor International's Hosier... mehr

Consumer health in Norway increased by 3% in current value terms in 2012; this was lower than the review period CAGR. The economic crisis in Europe in 2009 and 2011 was not able to affect spending, because consumer health is not very sensitive to economic fluctuations and financial crises. The largest categories, such as vitamins and dietary supplements and OTC products, saw modest growth in constant value terms, due to strong price com... mehr

Demand for consumer health in Tunisia increased strongly during 2012 as the industry enjoyed the highest growth in its history. The 11% value growth recorded in consumer health over the course of 2012 was due to a record rise in volume sales in the industry following, which itself was the result of several phenomena such as a sudden population increase due to an influx of people from troubled neighbour Libya and record-breaking cold tem... mehr

In 2012, vending continued to experience a fall in retail value sales. Consumers started to reduce their expenditure in 2009, as a result of the outbreak of the financial crisis in late 2008, and this attitude persisted until the end of the review period as the economic situation deteriorated. In 2012, vending registered a 2% decline in current value sales to reach CZK1.8 billion.

Euromonitor International's Vending in Czech ... mehr

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France


Summary


GlobalData, the industry analysis specialist, has released its new report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends... mehr

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy


Summary


GlobalData, the industry analysis specialist, has released its new report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcar... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

South Korea Pharmaceutical Market Outlook 2013


Summary


GBI Research’s new report 'South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and st... mehr

Consumer health maintained a stable and solid value performance over the review period until 2012. With stable unit prices, categories were able to continue to grow, enabled by higher buying power after a rise in minimum wages in 2012. Categories with higher profit margins, such as vitamins and dietary supplements witnessed strong growth, boosted by new product developments and higher consumer interest in general health and well-being.<... mehr

Consumer health retail value sales recorded positive growth in 2012, due to the good performance of vitamins and dietary supplements and sports nutrition. This growth was driven by success in dietary supplements, especially in combination products which offer various benefits in just one product. Increasing perception of dietary supplements as a safe way to improve health and prevent diseases and boost energy — necessary in coping... mehr

China’s consumer healthcare industry registered slower value sales growth in 2012 than in 2011, which was consistent with the general slowdown in most consumer goods industries in China, chiefly brought about by the continuing global economic difficulties. 2012 witnessed lower national GDP than in previous years, and a decline in consumer confidence also contributed to the slowdown in growth in China’s consumer health industry durin... mehr

The consumer health market in Finland did not only face the challenge of maturity, but also started to see effects from the economic downturn once again in 2012, as consumers were feeling more insecure about their purchasing power. Nonetheless, although some categories were struggling with static value growth, some younger categories saw healthy if not dynamic growth in the course of 2012.

Euromonitor International's Consumer... mehr

Consumer health witnessed declining value sales in 2012, unable to escape the general downturn of the Greek economy. Whilst the sector had managed to maintain a positive growth over the review period, with switches and price increases fuelling growth, this has not been the case for 2012. With prices remaining relatively stable and manufacturers abstaining from switches, value sales declined amidst the very unfavourable conditions of 201... mehr

Compared with the review period, the market in 2012 grew slightly higher in value, although it was lower compared to the previous year’s sales performance. Slightly faster growth in 2012 compared to the review period’s growth rate was achieved due to the increasing demand for expensive products; while in previous years, the double-digit growth rate was attributable mostly to the average unit price increase and general inflation rate... mehr

Rapidly recovering domestic consumption contributed to growth in consumer health sales in 2012. Higher volumes of standard products and returning demand for more expensive products supported the value sales over 2012. Ability to afford products of higher quality with specific content, which are suited better to individual needs compared to standard products, resulted in switches from mainstream products to more expensive remedies.
... mehr

Despite the second consecutive year of growth, the consumer health industry remained in a recessionary mood, judging by the actions of companies. The industry is generally considered as a stable one, resistant to external shocks of the economy. However, after deteriorating sales during the recession, firms turned to pricing as the chief tactic for competing. As a result, promotion campaigns that lasted for entire months and sometimes in... mehr

Consumer health enjoys steady development in Poland as a growing number of Poles feel confident with self-medicating. More Polish consumers understand the role of proper supplementation as well as the role of OTC medicines in preventing certain ailments. Manufacturers underpin the trend by running educational campaigns and introducing novelties on a regular basis, which help to arouse consumers’ interest and prompt purchases.
mehr

Sales of consumer health products in Sweden continue to increase despite a rapid slowdown of the Swedish economy. In 2012, consumer health saw value growth of 3% due to increasing self-medication and the ageing Swedish population. However, the growth rate was slower than the CAGR for the review period. This is primarily due to increased price competition caused by the launch of private label brands and an overcrowded pharmacy market. mehr

Despite major recalls and a weak cold and flu season further dragging down over-the-counter (OTC) sales, overall consumer health grew over 4% in 2012. Preventive health and wellness campaigns sustained strong sales in vitamins and dietary supplements, with manufacturers also introducing online assessments and mobile applications to support product selection. In addition, fitness trends and continued expansion from a niche to a mainstrea... mehr

The consumer health market in Uzbekistan continued its robust development in 2012, with double-digit current value growth. Ongoing urbanisation and solid cooperation between distributors and retailers created substantial demand for consumer health products, whilst continuously rising health awareness amongst consumers also helped to boost sales. The dynamism of consumer health was also underpinned by the steady development of the econom... mehr

Healthcare, Regulatory and Reimbursement Landscape - Argentina


Summary


Industry analysis specialist GlobalData has released its latest report 'Healthcare, Regulatory and Reimbursement Landscape - Argentina”. An essential source of information and analysis on the Argentina’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights... mehr

Healthcare, Regulatory and Reimbursement Landscape - Belgium


Summary


Industry analysis specialist GlobalData has released its latest report 'Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the ... mehr

Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Impr... mehr

Consumer health innovation is thriving, as manufacturers introduce creative new formulations, delivery formats and positionings to help people manage their unique health needs more effectively. Consumers’ busy lifestyles are driving the popularity of energy and calming products, as well as on-the-go delivery mechanisms. Economic uncertainty is creating more demand for cheaper options, while preventive treatments are addressing critica... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q1 2013


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q1 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. ... mehr

The good economic conditions prevailing in the country, with consumers’ purchasing power increasing in real terms year after year, allowed consumers to absorb price increases in several categories without reducing the volume of their purchases. The excellent performance in some of the larger categories such as analgesics, cough, cold and allergy (hay fever) remedies and weight management and the sustained good level of sales in most c... mehr

The good economic conditions prevailing in the country, with consumers’ purchasing power increasing in real terms year after year, allowed consumers to absorb price increases in several categories without reducing the volume of their purchases. The excellent performance in some of the larger categories such as analgesics, cough, cold and allergy (hay fever) remedies and weight management and the sustained good level of sales in most c... mehr

Healthcare, Regulatory and Reimbursement Landscape - Austria


Summary


Industry analysis specialist GlobalData has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Austria”. An essential source of information and analysis on Austria’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the... mehr

Healthcare, Regulatory and Reimbursement Landscape - Finland


Summary


Industry analysis specialist GlobalData has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Finland”. An essential source of information and analysis on the Finland’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into... mehr

Healthcare, Regulatory and Reimbursement Landscape - Norway


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Norway”. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Norway. It identifies key trends in the healthcare market and provi... mehr

Healthcare, Regulatory and Reimbursement Landscape - Portugal


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Portugal”. The report is an essential source of information on and analysis of the healthcare, regulatory, and reimbursement landscape in Portugal. It identifies key trends in the healthcare market and pro... mehr

Healthcare, Regulatory and Reimbursement Landscape - Sweden


Summary


GlobalData, the industry analysis specialist, has released its new report 'Healthcare, Regulatory and Reimbursement Landscape - Sweden”. The report is an essential source of information and analysis on Sweden’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insi... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012


Summary


GlobalData's 'Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provi... mehr

Bristol-Myers Squibb Co, a US-based producer of pharmaceutical and consumer health products, is making increasingly definite steps away from consumer health in order to re-position itself as a bio-pharma player. This has seen sales and share fall in a number of global markets, thanks to a mix of disposals and lack of investment. However, there remain solid opportunities in the product areas and geographies that the company still holds. ... mehr

Marktanalyse - Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Product Synopsis
'Global Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies' procurement expenditures, business str... mehr

Marktanalyse - Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Product Synopsis
'Global Pharmaceutical Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies' media spend, marketing and sales strategi... mehr

Global Pharmacy Automation Market 2012-2016

TechNavio's analysts forecast the Global Pharmacy Automation Market to grow at a CAGR of 8.63 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in technological innovations. The Global Pharmacy Automation market has also been witnessing an increase in customer support services. However, the intense competition among vendors ... mehr

Healthcare, Regulatory and Reimbursement Landscape - New Zealand


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - New Zealand”. The report is an essential source of information and analysis on New Zealand`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and... mehr

Healthcare, Regulatory and Reimbursement Landscape - Thailand


Summary


Industry analysis specialist GlobalData has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Thailand”. An essential source of information and analysis on the Thai healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the dem... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The repo... mehr

Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled, 'Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Product... mehr

Healthcare, Regulatory and Reimbursement Landscape - Jordan


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Jordan”. The report is an essential source of information and provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The report identifies the key trends in the healthcare ... mehr

Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment


Summary


GBI Research’s new report 'Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment” provides in-depth analysis of the trends, issues a... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. ... mehr

PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs


Summary


The Innovative Mid-Cap Biotech Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive position of 15 innovative biotech companies on 20 financial metrics. The performances of these companies ar... mehr

Consumer health retailers are continuously innovating in an effort to adapt to new regulatory policies, demographic preferences, technological developments and public health influences. Health and wellness trends are holding a great deal of sway over everything from store formats to marketing strategies. Younger consumers seek more internet and mobile shopping options, while ageing ones require different services. Companies are finding ... mehr

Selling consumer health is seeing an impressive transformation thanks to the explosion of digital media. Although the main marketing principles remain the same, the communication platform is moving to new and innovative channels. Advertisers and marketers are experimenting with creative and engaging campaigns in a bid to attract consumption and boost revenue. An intriguing development is the rise of 'mobile health”, which may rewrite ... mehr

Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share”, which provides insights into the glob... mehr

Healthcare, Regulatory and Reimbursement Landscape - Denmark


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Denmark”. The report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides in... mehr

Healthcare, Regulatory and Reimbursement Landscape - Israel


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Israel”. An essential source of information and analysis on the Israeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into... mehr

Healthcare, Regulatory and Reimbursement Landscape - South Africa


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - South Africa”. An essential source of information and analysis on the South African healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, a... mehr

Healthcare, Regulatory and Reimbursement Landscape - Venezuela


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Venezuela”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Venezuela. The report identifies the key trends in the healthcare mar... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Introduction

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals market. In... mehr

Healthcare, Regulatory and Reimbursement Landscape - Morocco


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Morocco”. An essential source of information and analysis on the Moroccan healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the Morocco healthcare market, as we... mehr

Healthcare, Regulatory and Reimbursement Landscape - Nigeria


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Nigeria”. An essential source of information and analysis on the Nigerian healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as provi... mehr

Healthcare, Regulatory and Reimbursement Landscape - The Netherlands


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - The Netherlands”. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies key trends in the ... mehr

Healthcare, Regulatory and Reimbursement Landscape - Turkey


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Turkey”. It is an essential source of information and analysis on Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights... mehr

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates”. An essential source of information and analysis on the Polish healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare ... mehr

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scop... mehr

Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovati... mehr

Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential ... mehr

Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within th... mehr

Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth are... mehr

Introduction

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuti... mehr

Introduction

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Australia pharmaceuticals m... mehr

Introduction

Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium pharmaceuticals marke... mehr

Introduction

Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Brazil pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China pharmaceuticals market. I... mehr

Introduction

Pharmaceuticals in Denmark industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Denmark pharmaceuticals marke... mehr

Introduction

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany pharmaceuticals marke... mehr

Introduction

Pharmaceuticals in Hungary industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Hungary pharmaceuticals marke... mehr

Introduction

Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the India pharmaceuticals market. I... mehr

Introduction

Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy pharmaceuticals market. I... mehr

Introduction

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan pharmaceuticals market. I... mehr

Introduction

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the New Zealand pharmaceutica... mehr

Introduction

Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Norway pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Poland industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Poland pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Russia pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Singapore pharmaceuticals m... mehr

Introduction

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa pharmaceuti... mehr

Introduction

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Korea pharmaceutica... mehr

Introduction

Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain pharmaceuticals market. I... mehr

Introduction

Pharmaceuticals in Sweden industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Sweden pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Taiwan pharmaceuticals market.... mehr

Introduction

Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Czech Republic pha... mehr

Introduction

Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands pharmaceu... mehr

Introduction

Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom pha... mehr

Introduction

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States pharm... mehr

Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an... mehr

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an e... mehr

In 2012, consumer health registered stronger value growth compared to the CAGR seen over the review period. Improved economic conditions in Azerbaijan are amongst the most important reasons for growth. Consumers remain value-orientated, seeking the best price for higher quality and safe products. Rising urbanisation is a very important factor for growth as the consumption of a number of products, such as cough, cold and allergy remedies... mehr

Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia”. An essential source of information and analysis on the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For September 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For September 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report p... mehr

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market


Summary


GBI Research’s new report, 'Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market”, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has ... mehr

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy”. This report examines the roles of Key Opinion Leaders (KOLs) within t... mehr

The world's third leading consumer health player GlaxoSmithKline (GSK) maintained its value share in 2011. Traditional treatment OTC brands performed strongly to offset declines of failing star Alli's sales in weight management. Acquisition of Maxinutrition indicates the company's increased focus on its nutritional business. Undergoing restructuring, Euromonitor International assesses its performance in 2011 and analyses its future pote... mehr

Marktanalyse - Healthcare Foodservice in Australia: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Australian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data o... mehr

Marktanalyse - Healthcare Foodservice in Austria: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Austrian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of th... mehr

Marktanalyse - Healthcare Foodservice in Belgium: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Belgian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the... mehr

Marktanalyse - Healthcare Foodservice in Canada: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Canadian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the... mehr

Marktanalyse - Healthcare Foodservice in Hungary: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Hungarian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of t... mehr

Marktanalyse - Healthcare Foodservice in Indonesia: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Indonesian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data o... mehr

Marktanalyse - Healthcare Foodservice in Italy: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Italian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the s... mehr

Marktanalyse - Healthcare Foodservice in Japan: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Japanese foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the ... mehr

Marktanalyse - Healthcare Foodservice in Mexico: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Mexican foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the ... mehr

Marktanalyse - Healthcare Foodservice in Poland: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Polish foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the s... mehr

Marktanalyse - Healthcare Foodservice in Russia: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Russian foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the ... mehr

Marktanalyse - Healthcare Foodservice in South Korea: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the South Korean foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales da... mehr

Marktanalyse - Healthcare Foodservice in Sweden: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Swedish foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the ... mehr

Marktanalyse - Healthcare Foodservice in Switzerland: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Swiss foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of t... mehr

Marktanalyse - Healthcare Foodservice in Turkey: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the Turkish foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales data of the ... mehr

Marktanalyse - Healthcare Foodservice in United States: Market Profile to 2016

Synopsis
This report presents detailed data on the Healthcare channel in the United States foodservice industry by analyzing key channel trends, market size and forecast and key channel indicators. The report examines the components of change in the channel looking at historic and future growth patterns. It provides historic and forecast sales... mehr

Healthcare, Regulatory and Reimbursement Landscape - Taiwan


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Taiwan”. It is an essential source of information and analysis on Taiwan’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights... mehr

Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance”. The report provides an ov... mehr

Introduction
Medtronic is the world’s fourth largest manufacturer of healthcare equipment in terms of market share (9.3%). It develops and markets products and therapies in the areas of cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose, and throat conditions.

Scope of this research
Mark... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report... mehr

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making


Summary


GBI Research, leading business intelligence provider has released its latest research report, entitled 'Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reim... mehr

Already one of the world’s largest consumer goods companies, Reckitt Benckiser Plc successfully made its headway into the global top 10 in consumer health industry in 2011. The company has invested heavily in its leading brands, often among the best-selling and most recognisable in their categories, and is reorganising itself to increase focus on its 'Powerbrands”, while shifting management resources to the world’s fastest-growing... mehr

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management


Summary


GBI Research, leading business intelligence provider has released its latest research report, entitled 'Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management”. The report focuses on the current scenario of clinical supply chai... mehr

TechNavio's analysts forecast the Global Contract Research Organization (CRO) market to grow at a CAGR of 10.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in outsourcing of R&D activities. The Global Contract Research Organization market has also been witnessing forward and backward integration by vendors. However, the strict government regulations on drug development ... mehr

Healthcare, Regulatory and Reimbursement Landscape - India


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - India”. The report is an essential source of information and analysis on India’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insigh... mehr

J&J continued to experience quality control issues which resulted in continued product recalls through 2011 and into early 2012. However, the company remained the market leader in the global OTC market despite significant share and sales erosion. Euromonitor International examines its performance over the past year and evaluates its future prospects in the lucrative growing consumer health market.



Euromonitor ... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends for July 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals andTrends for July 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends in Pharmaceuticals - Q2 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q2 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The rep... mehr

TechNavio's analysts forecast the Pharmaceutical market in Vietnam to grow at a CAGR of 18.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of diseases. The Pharmaceutical market in Vietnam has also been witnessing the trend of an increase in the number of awareness campaigns. However, poor regulatory standards in healthcare in Vietnam could pose a challenge to t... mehr

Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled 'Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins”.... mehr

TechNavio's analysts forecast the Pharmaceuticals market in Turkey to grow at a CAGR of 14.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the adoption of the Healthcare Transformation Program in Turkey. The Pharmaceuticals market in Turkey has also been witnessing the entry of foreign players. However, the low per capita spending on healthcare could pose a challenge to the growth of thi... mehr

Retail Clinics - 2012 Yearbook


Summary


GBI Research’s new report, 'Retail Clinics - 2012 Yearbook”, provides insights into the US retail clinic market, with coverage of the market landscape, key market trends, market drivers and restraints. The report provides market forecasts for the retail clinic industry until 2018 and the distribution of the retail clinics across the US. The key stakeholders and... mehr

Biobanks - 2012 Year Book


Summary


GBI Research, the leading business intelligence provider, has released its latest report, 'Biobanks - 2012 Year Book”. It provides key data, information and analysis of 37 of the world’s major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and ma... mehr

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings


Summary


GBI Research, the leading business intelligence provider, has released its latest research on, 'Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings”, which provides insights into the imp... mehr

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing” provides an in-depth analysis of the trends, issues and challenges in the... mehr

NBTY is one of the world’s top producers of vitamins and dietary supplements and sports nutrition products with over US$2.2 billion in retail value sales in 2011. The company, which also maintains a presence in the healthcare specialists retailing channel, faces unique challenges moving forward. In addition to increasing competition from traditional, pharmaceutical players, the company must work to pay off nearly US$2.5 billion in deb... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for June 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro... mehr

Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing


Summary


GBI Research, leading business intelligence provider, has released its latest research report, entitled 'Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenari... mehr

Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development


Summary


GBI Research, leading business intelligence provider, has released its latest research report, entitled 'Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development'. Over the last decade, protein and peptide-based therapeutics have attracted more and more attention in the pharmaceutical indus... mehr

Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled 'Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Managemen... mehr

With US$4.3 billion in retail value sales in 2011, Sanofi is one of the world’s top-ten consumer health producers. Through its strong commitment to growing its consumer health portfolio — through both Rx-to-OTC switches and acquisitions — the company witnessed its share of the global market increase steadily throughout the review period. While the company hopes to double its consumer health sales in the next two years, it ... mehr

Marktanalyse - Annual Marketing Budgets in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how business strategies and practices are set to change in the pharmaceutical industry in 2012-2013.
• Analysis on spending plans, challenges and investment opportunities for supply decision makers.
... mehr

Marktanalyse - Annual Procurement Budgets in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides data on the current size of procurement budgets of buyer companies in the pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclus... mehr

Bayer AG grew retail value sales by 6% in 2011 to top US$6 billion, as the company maintained the number two spot globally. Investments in innovation and promotional support helped sales in 2011, but the company will likely face more significant headwinds in its most important categories and markets looking forward. Continued investments in emerging markets and high-growth categories will be necessary to maintain its position as a leade... mehr

Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth


Summary


GBI Research, a leading business intelligence provider, has released its latest research 'Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth” which examines two major trends already impacting on marketing strategies in the global pharmaceutical enviro... mehr

Marktanalyse - Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of revenuue growth of global pharmaceutical industry.
• Analysis of future expectations for the growth prospects of pharmaceutical companies.

Summary
This report is the result of an extensive survey dr... mehr

Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011-2012.
• Analysis on spending plans, budget a... mehr

Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides data on the current size of procurement budgets of buyer companies in the pharmaceutical industry.
• Provides insight into the buying behaviors of the global pharmaceutical industry and market competition for supplie... mehr

Synopsis
Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Argentina to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the ... mehr

Synopsis
Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Mexico to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the ind... mehr

Synopsis
Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Myanmar to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the in... mehr

Synopsis
Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Vietnam to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the in... mehr

Marktanalyse - Critical Factors for Choosing a Marketing Agency in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how media spend, marketing, sales strategies and practices are set to change in the pharmaceutical industry in 2012-2013
• Analysis of the marketing and sales strategies of leading... mehr

Marktanalyse - Critical Success Factors for Supplier Selection in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• The report identifies and analyzes the most important criteria for supplier selection in the global pharmaceutical industry.

Summary
This report is the result of an extensive sur... mehr

Marktanalyse - Demand in Emerging Markets in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of the demand in emerging markets in the global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharm... mehr

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue” provides in-depth analysis of trends, issues and challenges in the pharmaceutic... mehr

Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment (FDI) in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment (FDI) in Indonesia and Extensive Insurance Coverage in the Philippines Attract... mehr

Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process” provides in-depth analysis of the trends, issues and challenges... mehr

Marktanalyse - Essential Amendments to Marketing Activities in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of essential amendments to marketing activities of global pharmaceutical industry in 2012-2013.

Summary
This report is the result of an extensive survey drawn from ICD Research�... mehr

Marktanalyse - E—Procurement in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• The report provides analysis on e-procurement in the global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceu... mehr

Marktanalyse - Future Developments in Business Structure in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of future expectations for the growth prospects of pharmaceutical companies.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive pan... mehr

Marktanalyse - Future Investment by Media Channel in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on the global pharmaceutical industry suppliers' future investment by media channel.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of... mehr

Marktanalyse - Future Procurement Objectives in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• The report provides future procurement objectives of the global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of lea... mehr

Marktanalyse - Growth Expectations in Developed Markets in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of market growth practices.
• Analysis on growth expectations in developed countries.

Summary
This report is the result of an extensive survey drawn from ICD Research’... mehr

Healthcare, Regulatory and Reimbursement Landscape - Philippines


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Philippines. The report identifies the key trends in the healt... mehr

Marktanalyse - Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides revenue growth expectations for the period 2012-2013.
• Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business s... mehr

Marktanalyse - Key Marketing Aims of Suppliers for Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of the key marketing aims for suppliers.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It an... mehr

Marktanalyse - Key Supplier Actions to Maintain and Win Buyer Business in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of the changing business dynamics in the pharmaceutical industry.
• Analysis on key supplier actions to maintain and win buyer business in the pharmaceutical industry. mehr

Marktanalyse - Leading Business Concerns in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of the changing business dynamics in the pharmaceutical industry.
• Analysis of the challenges faced by buyers and suppliers.


Summary
This report is the result of an extensive su... mehr

Marktanalyse - Market Growth Outlook in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of market growth practices.
• Analysis of the demand in emerging markets and growth expectations in developed countries.

Summary
This report is the result of an extensive survey drawn from ICD Resear... mehr

Marktanalyse - Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• The report identifies and analyzes the key marketing and sales strategies companies will be adopting to deal with market conditions in 2012-2013

Summary
This report is the result of an extensi... mehr

Marktanalyse - Merger and Acquisition Activity Expectations in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of Merger and Acquisition (M&A) activity in global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusi... mehr

Novartis remained a consumer health heavyweight in 2011, as retail value sales increased by 6% to US$5 billion. Despite its massive portfolio and broad OTC category exposure, the company needs to work to increase its scale in emerging markets, especially in the Asia Pacific and Latin America regions. Between Pfizer Inc’s recent acquisitions and Novartis’s recent North American manufacturing issues, the company will have a difficult ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for May 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures”. The report provides a comprehensive ov... mehr

This comprehensive company register includes the details of nearly 1000 pharmaceutical manufacturers around the world. The register is essential for companies who want to find out the leading players on the markets or are trying to find partners in different countries. The register contains the following details of the companies:

Company name
Contact details
Contact persons
Financial infomation<... mehr

Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits


Summary


GBI Research, the leading business intelligence provider, has released its new report 'Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits”. It analyzes the overall Supply Chain Management (SCM) scenario and provides profiles of the lea... mehr

Marktanalyse - Planned Change in Marketing Expenditure Levels in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on the changing marketing budgets in the pharmaceutical industry.
• Analysis on spending plans of supply decision makers.

Summary
This report is the result of an extensi... mehr

Marktanalyse - Planned Change in Procurement Expenditure in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides analysis on planned change in procurement expenditure in the pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s excl... mehr

Marktanalyse - Planned Change in Staff Recruitment Activity in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on planned change in staff recruitment activity in the global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s ... mehr

Marktanalyse - Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• The report identifies and analyzes the most important criteria for supplier selection from the point of view of both buyers and suppliers.

Summary
This report is the result of an extensive survey draw... mehr

Marktanalyse - Procurement Expenditure by Product and Service Category in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides analysis on procurement expenditure by product and service category in the pharmaceutical industry.

Summary
This report is the result of an extensive survey draw... mehr

Marktanalyse - Projection of Capital Expenditure in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on projections of capital expenditure of pharmaceutical companies.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading phar... mehr

Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making


Summary


GBI Research, a leading business intelligence provider, has released its latest research, 'Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making”, which examines the key issues influencing the re-evaluation of phar... mehr

Marktanalyse - Revenue Growth Expectations in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of revenuue growth of global pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry... mehr

Marktanalyse - Supplier Marketing Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Provides data on the current size of the marketing and advertising budgets of supplier companies in the pharmaceutical industry
• Provides insight into the marketing behaviors of the global pharmaceutical industr... mehr

Marktanalyse - Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how marketing expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2012-2013.
• Analysis on spending... mehr

Marktanalyse - Suppliers' Future Investment in Marketing and Sales Technology in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on the global pharmaceutical industry suppliers' future investment in marketing and sales.

Summary
This report is the result of an extensive survey drawn from I... mehr

Marktanalyse - Threats and Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis of the changing business dynamics in the pharmaceutical industry.
• Analysis of the challenges faced by buyers and suppliers.


Summary
This report is the result of an extensive survey drawn ... mehr

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provi... mehr

Marktanalyse - Use of New Media for Business Prospects in the Pharmaceutical Industry - 2012-2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on use of new media for business prospects in the pharmaceutical industry in 2012-2013.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive ... mehr

Marktanalyse - Variations in Regional Supplier Prices in the Pharmaceutical Industry - 2012—2013 : Survey Snapshot

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides analysis on variations in regional supplier practices in the pharmaceutical industry.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusi... mehr

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward”. Job losses within the pharmaceutical industry are a... mehr

Congress on Track to Overcome Partisan Gridlock and Keep the FDA Afloat


Summary


GlobalData's analysis alert 'Congress on Track to Overcome Partisan Gridlock and Keep the FDA Afloat' analyzes legislation recently passed by the United States Senate updating the Prescription Drug User Fee Act (PDUFA) and related provisions, which are set to expire at the end of September. Congress is locked in a pitched pa... mehr

Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Do... mehr

Healthcare, Regulatory and Reimbursement Landscape - Malaysia


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Malaysia”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Malaysia. The report identifies the key trends in the healthcare mar... mehr

Studie - 'Healthness'

mehr

Merck KGaA is a global top 20 producer of consumer health products. Despite relatively consistent revenue growth, the company has struggled to consistently gain share of the global consumer health market, due in large part to a significant absence from many of the world’s largest markets. The company could benefit greatly from increased acquisitive behaviour and a global consolidation of its overly broad portfolio, but it will need to... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report p... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends for April 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals andTrends for April 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro... mehr

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge”. The report examines the role of patients in cha... mehr

Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an... mehr

Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs”. It provides a comprehensive ove... mehr

Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs


Summary


GBI Research, the leading business intelligence provider, has released its latest report, 'Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in ... mehr

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs


Summary


GBI Research, the leading business intelligence provider, has released its latest report, 'Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Developm... mehr

Consumer health innovation is thriving, for example with novel and convenient delivery formats that integrate into consumers' fast-paced lifestyles. Global demographic shifts are driving demand for targeted products, and emerging markets are the source of many new offerings. Vitamins and dietary supplements, as well as formulations including herbal/traditional ingredients, are popular across all regions. Established products are explori... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Press... mehr

Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs through the DLO’s Seven Nosologies Program


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program”. It provides a co... mehr

As the world’s leading nutrition speciality retailer, General Nutrition Centers Inc is an increasingly important player in the global consumer health market. With its strong assortment of GNC-branded vitamins and dietary supplements, sports nutrition and weight management products, the company has enjoyed stable growth amidst global economic turmoil. Its exposure to the fast-growing categories of VDS and SN positions the company for c... mehr

Synopsis
• This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.

• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia... mehr

Synopsis
• This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.

• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and lea... mehr

Healthcare, Regulatory and Reimbursement Landscape - Singapore


Summary


GlobalData, the industry analysis specialist, has released its report, 'Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare mark... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Pfizer Inc’s consumer health brands witnessed strong growth in 2011, with the company ending the year with retail value sales of US$4.8 billion. Looking forward, Pfizer faces significant headwinds on account of overreliance on mature countries and the eventual return of recalled Johnson & Johnson products in its largest market. Inversely, the company’s significant room for category and geography expansion could result in above-a... mehr

Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”. It provides a comprehensive ov... mehr

Asia Pacific continues to deliver a wealth of growth prospects for consumer health companies and organisations. A large consumer base and untapped demand for self-care options create significant expansion opportunities for domestic, regional and multinational companies. However, regulatory hurdles, patent litigation and east versus west cultural differences pose important challenges to gaining access to the largest region in the world.<... mehr

Tensions Rising between Branded Drugmakers and Health Plans


Summary


GlobalData's new alert 'Tensions Rising between Branded Drugmakers and Health Plans' analyzes the Co-Pay Coupon lawsuit and the implications for branded drugmakers and health plan providers. Large pharmaceutical companies are in the midst of a wave of patent expirations that is threatening their profitability. As drugmakers face numerou... mehr

Euromonitor International examines the companies, brands and strategies that shaped the consumer health industry in 2011. This corporate strategies briefing will also highlight the issues facing the industry in the near future, examine the industry's reactions and preparedness, and highlight examples of successful and unsuccessful tactics for dealing with an evolving marketplace.

Euromonitor International’s Corporate Strate... mehr

Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in the Czech Republic. The report analyzes overall p... mehr

FDA Approves Erivedge (Vismodegib) for Metastatic or Locally Advanced Basal Cell Carcinoma


Summary


GlobalData, the industry analysis specialist, has released its new report, 'FDA Approves Erivedge (Vismodegib) for Metastatic or Locally Advanced Basal Cell Carcinoma”. The report is an essential source of information on the approval of Erivedge by the US FDA. The report also provides insights on the epi... mehr

Healthcare Providers - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Healthcare Providers industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
... mehr

Healthcare Providers - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems... mehr

Healthcare Providers - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and ... mehr

Healthcare Providers - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas... mehr

Healthcare Providers - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential ... mehr

Healthcare Providers: Global Industry Almanac is an essential resource for top-level data and analysis covering the Healthcare Providers industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* C... mehr

Healthcare Providers: Global Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Healthcare, Regulatory and Reimbursement Landscape - Brazil


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Brazil”. The report is an essential source of information and analysis on Brazil’s healthcare, regulatory and reimbursement landscape, and identifies the key trends in the healthcare market. The report als... mehr

Healthcare, Regulatory and Reimbursement Landscape - China


Summary


GlobalData, Industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - China”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of China. The report identifies the key trends in the Chinese healthcare market, as ... mehr

Healthcare, Regulatory and Reimbursement Landscape - France

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends in the healthcare market and provides i... mehr

Healthcare, Regulatory and Reimbursement Landscape - Germany

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Germany”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Germany. The report identifies the key trends in the healthcare market of Germany.... mehr

Healthcare, Regulatory and Reimbursement Landscape - Spain

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Spain”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Spain. The report identifies the key trends in the healthcare market of Spain. The rep... mehr

Healthcare, Regulatory and Reimbursement Landscape - UK

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - UK”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market of the UK. The report ... mehr

Healthcare, Regulatory and Reimbursement Landscape - US

Summary

Industry analysis specialist GlobalData, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the US. It identifies the key trends in the healthcare market of the US and provides insights on ... mehr

Impact of Eurozone Crisis on Healthcare Economics


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Impact of Eurozone Crisis on Healthcare Economics”. The report is an essential source of information for the analysis on the impact of the Eurozone crisis on the healthcare economics. The report reviews various measures employed in the healthcare sector in order to aver... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure fo... mehr

Healthcare, Regulatory and Reimbursement Landscape - Italy

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Italy. The report identifies the key trends in the healthcare market of Italy. The rep... mehr

Healthcare, Regulatory and Reimbursement Landscape - Japan

Summary

GlobalData, the industry analysis specialist, has released its report, 'Healthcare, Regulatory and Reimbursement Landscape - Japan”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Japan. The report identifies the key trends in the healthcare market of Japan. The report ... mehr

Contrary to popular belief, keeping children healthy is not that easy. Intensifying regulatory oversight and concerns regarding proper health literacy among adults have created additional burdens on paediatric health. Moreover, the child population now faces higher rates of non-communicable chronic conditions due to unhealthy lifestyles. Future prevention and treatment of paediatric conditions will come in the form of safer formulations... mehr

Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential ... mehr

Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within th... mehr

Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth are... mehr

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an e... mehr

Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Summary

GlobalData's 'Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on licensing agreements in the pharmaceuticals industry. The report provides detailed information on licensing transactions registered in the pharmaceuticals industry in Q3 2011. The report ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Pharmaceutical Packaging Industry - 2011 Yearbook

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Pharmaceutical Packaging Industry - 2011 Yearbook” which provides insights into the global pharmaceutical packaging market and information on market forecasts until 2017. In addition to this, the geographical distribution of pharmaceutical packaging manufacturers ac... mehr

Synopsis
WMI's 'Chemical & Pharmaceutical Plant Construction in Argentina to 2015: Market Snapshot' contains detailed historic and forecast construction market value of the overall category in which it is classified.

Summary
This report is the result of WMI’s extensive market research covering the chemical & pharmaceutical plant construction market in Argentina. It provides detailed historic and forecast c... mehr

Synopsis
WMI's 'Chemical & Pharmaceutical Plant Construction in Peru to 2015: Market Snapshot' contains detailed historic and forecast construction market value of the overall category in which it is classified.

Summary
This report is the result of WMI’s extensive market research covering the chemical & pharmaceutical plant construction market in Peru. It provides detailed historic and forecast constructio... mehr

Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Summary

GlobalData's 'Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on cross border mergers and acquisitions (M&As) and asset transactions in the pharmaceuticals industry. The report provides detailed information on cross border and... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

Synopsis
• The report is based on primary surveys conducted by ICD Research accessing its B2B panels comprised of senior business decision makers. The opinions and forward looking statements on sustainability management of 287 industry executives are captured in our in-depth survey, of which 44% represent directors, C-level executives and departmental heads.

• The geographical scope of the research is global — ... mehr

Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

Summary

GBI Research’s report, 'Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape” provides detailed ins... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how business strategies and practices are set to change in the pharmaceutical industry in 2011—2012
• Analysis on spending plans, challenges and investment opportunities for supply decision makers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive pane... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how business strategies and practices are set to change in the pharmaceutical industry in 2011—2012
• Analysis on spending plans, challenges and investment opportunities for purchase decision makers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive pa... mehr

Boehringer Ingelheim is a German-based, family-owned pharmaceutical company with a strong position in consumer health. While other major pharmaceutical companies, such as Bristol-Myers Squibb, are reducing their commitment to consumer products, Boehringer Ingelheim is looking to build its presence.

Euromonitor International’s Boehringer Ingelheim in Consumer Health (World) Company Profile offers detailed strategic analysi... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011—2012
• Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers

Summary
This report is the result of an extensive sur... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Provides data on the current size of procurement budgets of buyer companies in the pharmaceutical industry
• Provides insight into the buying behaviors of the global pharmaceutical industry and market competition for supplier companies

Summary
This report is the result of an extensive survey drawn from ICD Resear... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on the changing marketing budgets in the pharmaceutical industry
• Analysis on spending plans of supply decision makers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how spending activities a... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on procurement expenditure on products and services in the pharmaceutical industry.
• Analysis on spending plans, challenges and investment opportunities for purchase decision makers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceu... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on the changing procurement budgets in the pharmaceutical industry
• Analysis on spending plans of purchase decision makers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how spending activiti... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how media spend, marketing, sales strategies and practices are set to change in the pharmaceutical industry in 2011—2012
• Analysis of the marketing and sales strategies of leading pharmaceutical industry suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research�... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how market growth practices are set to change in the pharmaceutical industry in 2011—2012
• Analysis on demand in emerging markets

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how ... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how market growth practices are set to change in the pharmaceutical industry in 2011—2012
• Analysis on growth expectations in developed countries

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. ... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Provides revenue growth expectations for the period 2011—2012
• Provides detail on growth prospects and changes in the competitive landscape in terms of mergers and acquisitions

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical ind... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Provides revenue growth expectations for the period 2011—2012
• Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business structure
• Analysis of the demand in emerging markets and growth expectations in developed countries
• Analysis of the changing... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis of the key marketing aims for suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how marketing expenditure, business strategies and practices in the pharmaceutical industry are set to change in... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how marketing expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011—2012
• Analysis on spending plans, budget allocations, challenges and investment opportunities of supply decision makers

Summary
This report is the result of an extensive survey ... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• The report identifies and analyzes the key marketing and sales strategies companies will be adopting to deal with market conditions in 2011—2012

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes the changi... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides deta... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• The report identifies and analyzes the most important criteria for supplier selection from the point of view of both buyers and suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes the changing procuremen... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how revenue growth expectations are set to change in the pharmaceutical industry in 2011—2012

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how business strategies and practices are set to ... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis of the critical success factors considered by both buyers and suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how procurement expenditure, business strategies and practices in the pharmaceut... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on the challenges faced by suppliers in the pharmaceutical industry
• Analysis on how suppliers in the pharmaceutical industry can secure business from buyers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Provides data on the current size of the marketing and advertising budgets of supplier companies in the Packaging industry
• Provides insight into the marketing behaviors of the global pharmaceutical industry and market competition for supplier companies

Summary
This report is the result of an extensive survey dr... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis of market growth practices
• Analysis of the demand in emerging markets and growth expectations in developed countries

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading '&LOWER(C41)&' industry executives. It analyzes how demand and g... mehr

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis of the changing business dynamics in the pharmaceutical industry
• Analysis of the challenges faced by buyers and suppliers

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes the future business c... mehr

Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Acne Therapeutics market. The report identifies the key trends shaping and driving the global Acne Therapeutics mark... mehr

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth”. The report provides in-depth ana... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Australia to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Australia. It provides detailed histori... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Bahrain to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the chemical & pharmaceutical plant construction market in Bahrain. It provides detailed historic an... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Canada to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Canada. It provides detailed historic and ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Colombia to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Colombia. It provides detailed historic ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in France to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in France. It provides detailed historic and ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Italy to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Italy. It provides detailed historic and fo... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Japan to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the chemical & pharmaceutical plant construction market in Japan. It provides detailed historic and fo... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Qatar to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the chemical & pharmaceutical plant construction market in Qatar. It provides detailed historic and fo... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Russia to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Russia. It provides detailed historic and ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Russia to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Russia. It provides detailed historic and ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Saudi Arabia to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the chemical & pharmaceutical plant construction market in Saudi Arabia. It provides detailed h... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Switzerland to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the chemical & pharmaceutical plant construction market in Switzerland. It provides detailed his... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in Turkey to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in Turkey. It provides detailed historic and ... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in UK to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in UK. It provides detailed historic and forecast... mehr

Synopsis
ICD Research's, Chemical & Pharmaceutical Plant Construction in US to 2015: Market Snapshot contains detailed historic and forecast construction sales value of the overall category in which it is classified.

Summary
This report is the result of ICD Research’s extensive market research covering the Chemical & Pharmaceutical Plant Construction market in US. It provides detailed historic and forecast... mehr

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”, provides in... mehr

Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles

Summary

GBI Research's report, 'Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles” provides in-depth analysis of drivers and barriers that impact the global critical care market. The rep... mehr

Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Cystic Fibrosis Therapeutics market. The report identifies the key trends shaping an... mehr

Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013

Summary

GBI Research’s new report, 'Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the ... mehr

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Idiopathic Pulmonary Fibrosis Therapeutics market. The... mehr

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

Summary

GBI Research’s report, 'Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysis of the, drivers and barriers that affect the global ... mehr

Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs

Summary

GBI Research has released its latest research 'Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs”, which provides insights into effective innovative strategies adopted by the pharmaceutica... mehr

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity

Summary

GBI Research has released its latest research, 'Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity” which provides insights into the licensing agreements of large pharmaceutical companies. The ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides ... mehr

Pharmaceutical Partnership Deal Terminations

Summary

GBI Research, the leading business intelligence provider, has released its latest report, 'Pharmaceutical Partnership Deal Terminations” which provides key data, information and analysis of the major deals terminated in pharma industry in the period January, 2010, to June, 2011. The report provides a comprehensive insight into the partner companies involved in ... mehr

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Summary

GBI Research has released its latest report, 'Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance” that provides key data, information and analysis of the major trends and developments in post marketing... mehr

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

Summary

GBI Research has released its latest research 'Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Ph... mehr

Amway is the world leader in direct sales in the consumer health market. Its global growth has been driven in recent years by its expanding presence in the emerging markets, most notably China, where it is the leader overall in the VDS category. The company’s fortunes, however, have not been as positive in the US market, where it has faced competition from fellow direct seller Herbalife in the weight management category.

E... mehr

Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Anemia Therapeutics market. The report identifies the key trends shaping and driving the global Anemia Therapeut... mehr

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Chronic Obstructive Pulmonary Diseas... mehr

Eli Lilly and Company — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Eli Lilly & Company - Product Pipeline Review - Q2 2011” provides data on the Eli Lilly & Company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects... mehr

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

Summary

GBI Research’s report, 'Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force”, provides in-depth analysis of trends, issues and challenges in the Indian pharmaceutical i... mehr

Johnson & Johnson — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Johnson & Johnson - Product Pipeline Review - Q2 2011” provides data on the Johnson & Johnson’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. mehr

Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Nonalcoholic Steatohepatitis (NASH) Therapeutics marke... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - August 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — August 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis

Summary

GlobalData, the industry analysis specialist, has released its new conference alerts, '71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease man... mehr

ACADIA Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'ACADIA Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the ACADIA Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and do... mehr

Actelion Ltd — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Actelion Ltd - Product Pipeline Review - Q2 2011” provides data on the Actelion Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is bu... mehr

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

Summary

GBI Research’s report, 'Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases” provides detailed insight into the Asia-Pacific API market. The research pr... mehr

Alkermes, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Alkermes, Inc. - Product Pipeline Review - Q2 2011” provides data on the Alkermes, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

AlphaVax, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'AlphaVax, Inc. - Product Pipeline Review - Q2 2011” provides data on the AlphaVax, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

Anavex Life Sciences Corp. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Anavex Life Sciences Corp. - Product Pipeline Review - Q2 2011” provides data on the Anavex Life Sciences Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Aquinox Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Aquinox Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Aquinox Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and... mehr

Ark Therapeutics Group plc — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Ark Therapeutics Group plc - Product Pipeline Review - Q2 2011” provides data on the Ark Therapeutics Group plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

ARQULE, INC — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'ARQULE, INC - Product Pipeline Review - Q2 2011” provides data on the ARQULE, INC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built... mehr

Ausgaben von Endkunden für Telekommunikations-Verbindungsentgelte in 6 Produktgruppen plus Aggregation. Die Standardlieferung ist aufgeteilt nach Gesamt, Großunternehmen mit mehr als 1000 Beschäftigten, Mittelstand und Kleinunternehmen mit weniger als 100 Beschäftigten. Alternativ kann eine Aufteilung geliefert werden nach Umsatz der Unternehmen. Bitte bei Bestellung angeben.... mehr

Ausgaben von Endkunden für Telekommunikations-Verbindungsentgelte in 6 Produktgruppen plus Aggregation. Die Standardlieferung ist aufgeteilt nach Gesamt, Großunternehmen mit mehr als 1000 Beschäftigten, Mittelstand und Kleinunternehmen mit weniger als 100 Beschäftigten. Alternativ kann eine Aufteilung geliefert werden nach Umsatz der Unternehmen. Bitte bei Bestellung angeben.... mehr

AVEO Pharmaceuticals, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'AVEO Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the AVEO Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Basilea Pharmaceutica Ltd. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Basilea Pharmaceutica Ltd. - Product Pipeline Review - Q2 2011” provides data on the Basilea Pharmaceutica Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Bavarian Nordic A/S — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Bavarian Nordic A/S - Product Pipeline Review - Q2 2011” provides data on the Bavarian Nordic A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

BioMarin Pharmaceutical Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'BioMarin Pharmaceutical Inc. - Product Pipeline Review - Q2 2011” provides data on the BioMarin Pharmaceutical Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and... mehr

Celldex Therapeutics, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Celldex Therapeutics, Inc. - Product Pipeline Review - Q2 2011” provides data on the Celldex Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Celltrion, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Celltrion, Inc. - Product Pipeline Review - Q2 2011” provides data on the Celltrion, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This rep... mehr

Chiesi Farmaceutici SpA — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Chiesi Farmaceutici SpA - Product Pipeline Review - Q2 2011” provides data on the Chiesi Farmaceutici SpA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projec... mehr

Compugen Ltd. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Compugen Ltd. - Product Pipeline Review - Q2 2011” provides data on the Compugen Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is... mehr

Critical Outcome Technologies Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Critical Outcome Technologies Inc. - Product Pipeline Review - Q2 2011” provides data on the Critical Outcome Technologies Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features o... mehr

Cyclacel Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Cyclacel Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued ... mehr

Digna Biotech, S.L. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Digna Biotech, S.L. - Product Pipeline Review - Q2 2011” provides data on the Digna Biotech, S.L.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

Endo Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Endo Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Endo Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant ... mehr

Endocyte, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Endocyte, Inc. - Product Pipeline Review - Q2 2011” provides data on the Endocyte, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

Enzo Biochem, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Enzo Biochem, Inc. - Product Pipeline Review - Q2 2011” provides data on the Enzo Biochem, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

mehr

Eurofarma — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Eurofarma - Product Pipeline Review - Q2 2011” provides data on the Eurofarma’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using... mehr

Five Prime Therapeutics, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Five Prime Therapeutics, Inc. - Product Pipeline Review - Q2 2011” provides data on the Five Prime Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued ... mehr

Galapagos NV — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Galapagos NV - Product Pipeline Review - Q2 2011” provides data on the Galapagos NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is bu... mehr

Genfit — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Genfit - Product Pipeline Review - Q2 2011” provides data on the Genfit’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and... mehr

GenPhar, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'GenPhar, Inc. - Product Pipeline Review - Q2 2011” provides data on the GenPhar, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is... mehr

Glenmark Pharmaceuticals Ltd. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - Q2 2011” provides data on the Glenmark Pharmaceuticals Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued ... mehr

Synopsis

• Analysis of opinions drawn from leading medical device industry executives
• Analysis on how medical device companies’ procurement expenditure, business strategies and practices are set to change in 2011—2012
• Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers


Summary

This report is the result of a... mehr

Synopsis
• Analysis of opinions drawn from leading medical device industry executives
• Analysis on how medical device industry suppliers’ media spend, marketing and sales strategies and practices are set to change in 2011—2012
• Analysis on spending plans, media budget allocations, challenges and sales strategies of leading medical device industry suppliers


Summary
This report is the ... mehr

Synopsis

• Analysis of opinions drawn from leading pharmaceutical industry executives
• Analysis on how pharmaceutical companies’ media spend, marketing and sales strategies and practices are set to change in 2011—2012
• Analysis on spending plans, media budget allocations, challenges and sales strategies of leading pharmaceutical industry suppliers


Summary

This report is t... mehr